SI-BONE, Inc. delivered a strong performance in Q4 2024, with worldwide revenue reaching $49.0 million, a 26% increase year-over-year, and achieving positive adjusted EBITDA of $1.9 million, marking a significant improvement from the previous year.
Worldwide revenue grew by approximately 26% to $49.0 million in Q4 2024.
U.S. revenue increased by approximately 28% to $46.9 million in Q4 2024.
The company achieved positive adjusted EBITDA of $1.9 million in Q4 2024, a 139% improvement.
Net loss improved by 59% to $4.5 million in Q4 2024.
SI-BONE expects 2025 worldwide revenue to be in the range of $193.5 million to $195.5 million, implying year-over-year growth of 16% to 17%. The company anticipates gross margin between 77% and 78%, and operating expenses growth of approximately 9% at the mid-point of revenue guidance. Based on these assumptions, SI-BONE expects to deliver positive adjusted EBITDA for the second half and full year 2025.
Visualization of income flow from segment revenue to net income